{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T15:19:21Z","timestamp":1706109561555},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T00:00:00Z","timestamp":1666137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T00:00:00Z","timestamp":1666137600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Schmerz"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s00482-022-00669-3","type":"journal-article","created":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T07:02:51Z","timestamp":1666162971000},"page":"447-457","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Diagnostik und Therapie klinisch relevanter paraneoplastischer Syndrome"],"prefix":"10.1007","volume":"36","author":[{"given":"Katharina","family":"Sch\u00fctte","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karolin","family":"Trautmann-Grill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,10,19]]},"reference":[{"key":"669_CR1","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s00405-005-0942-1","volume":"263","author":"LWJ Baijens","year":"2006","unstructured":"Baijens\u00a0LWJ, Manni\u00a0JJ (2006) Paraneoplastic syndromes in patients with primary malignancies of the head and neck. Four cases and a\u00a0review of the literature. Eur Arch Otorhinolaryngol 263:32\u201336. https:\/\/doi.org\/10.1007\/s00405-005-0942-1","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"669_CR2","doi-asserted-by":"publisher","first-page":"838","DOI":"10.4065\/mcp.2010.0099","volume":"85","author":"LC Pelosof","year":"2010","unstructured":"Pelosof\u00a0LC, Gerber\u00a0DE (2010) Paraneoplastic syndromes: an approach to diagnosis and treatment. Mayo Clin Proc 85:838\u2013854. https:\/\/doi.org\/10.4065\/mcp.2010.0099","journal-title":"Mayo Clin Proc"},{"key":"669_CR3","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1002\/cncr.27772","volume":"119","author":"AA Khorana","year":"2013","unstructured":"Khorana\u00a0AA, Dalal\u00a0M, Lin\u00a0J, Connolly\u00a0GC (2013) Incidence and predictors of venous thromboembolism (VTE) among ambulatory high-risk cancer patients undergoing chemotherapy in the United States. Cancer 119:648\u2013655. https:\/\/doi.org\/10.1002\/cncr.27772","journal-title":"Cancer"},{"key":"669_CR4","doi-asserted-by":"publisher","first-page":"52","DOI":"10.5482\/HAMO-14-08-0037","volume":"35","author":"C Dicke","year":"2015","unstructured":"Dicke\u00a0C, Langer\u00a0F (2015) Pathophysiology of Trousseau\u2019s syndrome. Hamostaseologie 35:52\u201359. https:\/\/doi.org\/10.5482\/HAMO-14-08-0037","journal-title":"Hamostaseologie"},{"key":"669_CR5","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.1002\/onco.13584","volume":"26","author":"C O\u2019Connell","year":"2021","unstructured":"O\u2019Connell\u00a0C, Escalante\u00a0CP, Goldhaber\u00a0SZ et al (2021) Treatment of cancer-associated venous thromboembolism with low-molecular-weight heparin or direct oral anticoagulants: patient selection, controversies, and caveats. Oncologist 26:e8\u2013e16. https:\/\/doi.org\/10.1002\/onco.13584","journal-title":"Oncologist"},{"key":"669_CR6","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1055\/s-0040-1715795","volume":"47","author":"A Winther-Larsen","year":"2021","unstructured":"Winther-Larsen\u00a0A, Sandfeld-Paulsen\u00a0B, Hvas\u00a0A\u2011M (2021) Hyperfibrinolysis in patients with solid malignant neoplasms: a systematic review. Semin Thromb Hemost 47:581\u2013588. https:\/\/doi.org\/10.1055\/s-0040-1715795","journal-title":"Semin Thromb Hemost"},{"key":"669_CR7","doi-asserted-by":"publisher","first-page":"101621","DOI":"10.1016\/j.beem.2022.101621","volume":"36","author":"MC Onyema","year":"2022","unstructured":"Onyema\u00a0MC, Drakou\u00a0EE, Dimitriadis\u00a0GK (2022) Endocrine abnormality in paraneoplastic syndrome. Best Pract Res Clin Endocrinol Metab 36:101621. https:\/\/doi.org\/10.1016\/j.beem.2022.101621","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"669_CR8","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s00108-017-0377-y","volume":"59","author":"N Reisch","year":"2018","unstructured":"Reisch\u00a0N, Reincke\u00a0M (2018) Endokrine paraneoplastische Syndrome. Internist 59:125\u2013133. https:\/\/doi.org\/10.1007\/s00108-017-0377-y","journal-title":"Internist"},{"key":"669_CR9","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1200\/JOP.2016.011155","volume":"12","author":"W Goldner","year":"2016","unstructured":"Goldner\u00a0W (2016) Cancer-related hypercalcemia. J\u00a0Oncol Pract 12:426\u2013432. https:\/\/doi.org\/10.1200\/JOP.2016.011155","journal-title":"J Oncol Pract"},{"key":"669_CR10","doi-asserted-by":"publisher","first-page":"499","DOI":"10.7326\/0003-4819-112-7-499","volume":"112","author":"SH Ralston","year":"1990","unstructured":"Ralston\u00a0SH, Gallacher\u00a0SJ, Patel\u00a0U et al (1990) Cancer-associated hypercalcemia: morbidity and mortality. Clinical experience in 126 treated patients. Ann Intern Med 112:499\u2013504. https:\/\/doi.org\/10.7326\/0003-4819-112-7-499","journal-title":"Ann Intern Med"},{"key":"669_CR11","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1056\/NEJMcp042806","volume":"352","author":"AF Stewart","year":"2005","unstructured":"Stewart\u00a0AF (2005) Clinical practice. Hypercalcemia associated with cancer. N\u00a0Engl J Med 352:373\u2013379. https:\/\/doi.org\/10.1056\/NEJMcp042806","journal-title":"N Engl J Med"},{"key":"669_CR12","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1210\/jcem-48-3-393","volume":"48","author":"JH Ladenson","year":"1979","unstructured":"Ladenson\u00a0JH, Lewis\u00a0JW, McDonald\u00a0JM et\u00a0al (1979) Relationship of free and total calcium in hypercalcemic conditions. J\u00a0Clin Endocrinol Metab 48:393\u2013397. https:\/\/doi.org\/10.1210\/jcem-48-3-393","journal-title":"J Clin Endocrinol Metab"},{"key":"669_CR13","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-13-1020","volume":"170","author":"G Spasovski","year":"2014","unstructured":"Spasovski\u00a0G, Vanholder\u00a0R, Allolio\u00a0B et\u00a0al (2014) Clinical practice guideline on diagnosis and treatment of hyponatraemia. Eur J Endocrinol 170:G1\u2013G47. https:\/\/doi.org\/10.1530\/EJE-13-1020","journal-title":"Eur J Endocrinol"},{"key":"669_CR14","doi-asserted-by":"publisher","first-page":"G9","DOI":"10.1530\/EC-16-0055","volume":"5","author":"J Walsh","year":"2016","unstructured":"Walsh\u00a0J, Gittoes\u00a0N, Selby\u00a0P, Society for Endocrinology Clinical Committee (2016) Society for Endocrinology endocrine emergency guidance: emergency management of acute hypercalcaemia in adult patients. Endocr Connect 5:G9\u2013G11. https:\/\/doi.org\/10.1530\/EC-16-0055","journal-title":"Endocr Connect"},{"key":"669_CR15","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1093\/annonc\/mdr435","volume":"23","author":"F Saad","year":"2012","unstructured":"Saad\u00a0F, Brown\u00a0JE, Van Poznak\u00a0C et al (2012) Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases. Ann Oncol 23:1341\u20131347. https:\/\/doi.org\/10.1093\/annonc\/mdr435","journal-title":"Ann Oncol"},{"key":"669_CR16","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s00520-003-0477-1","volume":"11","author":"M Pecherstorfer","year":"2003","unstructured":"Pecherstorfer\u00a0M, Steinhauer\u00a0EU, Rizzoli\u00a0R et\u00a0al (2003) Efficacy and safety of ibandronate in the treatment of hypercalcemia of malignancy: a\u00a0randomized multicentric comparison to pamidronate. Support Care Cancer 11:539\u2013547. https:\/\/doi.org\/10.1007\/s00520-003-0477-1","journal-title":"Support Care Cancer"},{"key":"669_CR17","doi-asserted-by":"publisher","first-page":"6253","DOI":"10.21037\/jtd.2020.03.88","volume":"12","author":"Z Soomro","year":"2020","unstructured":"Soomro\u00a0Z, Youssef\u00a0M, Yust-Katz\u00a0S et al (2020) Paraneoplastic syndromes in small cell lung cancer. J\u00a0Thorac Dis 12:6253\u20136263. https:\/\/doi.org\/10.21037\/jtd.2020.03.88","journal-title":"J Thorac Dis"},{"key":"669_CR18","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s00415-019-09544-1","volume":"267","author":"A Vogrig","year":"2020","unstructured":"Vogrig\u00a0A, Gigli\u00a0GL, Segatti\u00a0S et al (2020) Epidemiology of paraneoplastic neurological syndromes: a\u00a0population-based study. J\u00a0Neurol 267:26\u201335. https:\/\/doi.org\/10.1007\/s00415-019-09544-1","journal-title":"J Neurol"},{"key":"669_CR19","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1056\/NEJMra023009","volume":"349","author":"RB Darnell","year":"2003","unstructured":"Darnell\u00a0RB, Posner\u00a0JB (2003) Paraneoplastic syndromes involving the nervous system. N\u00a0Engl J Med 349:1543\u20131554. https:\/\/doi.org\/10.1056\/NEJMra023009","journal-title":"N Engl J Med"},{"key":"669_CR20","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1136\/practneurol-2021-003073","volume":"22","author":"S Binks","year":"2022","unstructured":"Binks\u00a0S, Uy\u00a0C, Honnorat\u00a0J, Irani\u00a0SR (2022) Paraneoplastic neurological syndromes: a\u00a0practical approach to diagnosis and management. Pract Neurol 22:19\u201331. https:\/\/doi.org\/10.1136\/practneurol-2021-003073","journal-title":"Pract Neurol"},{"key":"669_CR21","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1136\/jnnp.2003.034447","volume":"75","author":"F Graus","year":"2004","unstructured":"Graus\u00a0F, Delattre\u00a0JY, Antoine\u00a0JC et\u00a0al (2004) Recommended diagnostic criteria for paraneoplastic neurological syndromes. J\u00a0Neurol Neurosurg Psychiatry 75:1135\u20131140. https:\/\/doi.org\/10.1136\/jnnp.2003.034447","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"669_CR22","doi-asserted-by":"publisher","first-page":"e1014","DOI":"10.1212\/NXI.0000000000001014","volume":"8","author":"F Graus","year":"2021","unstructured":"Graus\u00a0F, Vogrig\u00a0A, Mu\u00f1iz-Castrillo\u00a0S et al (2021) Updated diagnostic criteria for paraneoplastic neurologic syndromes. Neurol Neuroimmunol Neuroinflamm 8:e1014. https:\/\/doi.org\/10.1212\/NXI.0000000000001014","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"669_CR23","first-page":"433","volume":"22","author":"I Blyakhman","year":"2019","unstructured":"Blyakhman\u00a0I, Chakravarthy\u00a0K (2019) Updated review and treatment recommendations on paraneoplastic neurologic syndromes and chronic pain. Pain Phys 22:433\u2013445","journal-title":"Pain Phys"},{"key":"669_CR24","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s40122-017-0091-4","volume":"6","author":"D Fornasari","year":"2017","unstructured":"Fornasari\u00a0D (2017) Pharmacotherapy for neuropathic pain: a review. Pain Ther 6:25\u201333. https:\/\/doi.org\/10.1007\/s40122-017-0091-4","journal-title":"Pain Ther"},{"key":"669_CR25","doi-asserted-by":"publisher","first-page":"CD007625","DOI":"10.1002\/14651858.CD007625.pub2","volume":"12","author":"B Giometto","year":"2012","unstructured":"Giometto\u00a0B, Vitaliani\u00a0R, Lindeck-Pozza\u00a0E et al (2012) Treatment for paraneoplastic neuropathies. Cochrane Database Syst Rev 12:CD7625. https:\/\/doi.org\/10.1002\/14651858.CD007625.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"669_CR26","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.3390\/brainsci11111414","volume":"11","author":"PA Loehrer","year":"2021","unstructured":"Loehrer\u00a0PA, Zieger\u00a0L, Simon\u00a0OJ (2021) Update on paraneoplastic cerebellar degeneration. Brain Sci 11:1414. https:\/\/doi.org\/10.3390\/brainsci11111414","journal-title":"Brain Sci"},{"key":"669_CR27","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s40122-017-0076-3","volume":"6","author":"P Zis","year":"2017","unstructured":"Zis\u00a0P, Paladini\u00a0A, Piroli\u00a0A et al (2017) Pain as a\u00a0first manifestation of paraneoplastic neuropathies: a systematic review and meta-analysis. Pain Ther 6:143\u2013151. https:\/\/doi.org\/10.1007\/s40122-017-0076-3","journal-title":"Pain Ther"},{"key":"669_CR28","doi-asserted-by":"publisher","first-page":"706169","DOI":"10.3389\/fneur.2021.706169","volume":"12","author":"M Zoccarato","year":"2021","unstructured":"Zoccarato\u00a0M, Grisold\u00a0W, Grisold\u00a0A et\u00a0al (2021) Paraneoplastic neuropathies: what\u2019s new since the 2004 recommended diagnostic criteria. Front Neurol 12:706169. https:\/\/doi.org\/10.3389\/fneur.2021.706169","journal-title":"Front Neurol"},{"key":"669_CR29","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.semarthrit.2014.03.005","volume":"44","author":"B Manger","year":"2014","unstructured":"Manger\u00a0B, Schett\u00a0G (2014) Palmar fasciitis and polyarthritis syndrome-systematic literature review of 100\u00a0cases. Semin Arthritis Rheum 44:105\u2013111. https:\/\/doi.org\/10.1016\/j.semarthrit.2014.03.005","journal-title":"Semin Arthritis Rheum"},{"key":"669_CR30","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.clim.2017.07.021","volume":"186","author":"B Manger","year":"2018","unstructured":"Manger\u00a0B, Schett\u00a0G (2018) Rheumatic paraneoplastic syndromes\u2014a clinical link between malignancy and autoimmunity. Clin Immunol 186:67\u201370. https:\/\/doi.org\/10.1016\/j.clim.2017.07.021","journal-title":"Clin Immunol"},{"key":"669_CR31","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1093\/rheumatology\/keab166","volume":"60","author":"AGS Oldroyd","year":"2021","unstructured":"Oldroyd\u00a0AGS, Allard\u00a0AB, Callen\u00a0JP et al (2021) A systematic review and meta-analysis to inform cancer screening guidelines in idiopathic inflammatory myopathies. Rheumatology 60:2615\u20132628. https:\/\/doi.org\/10.1093\/rheumatology\/keab166","journal-title":"Rheumatology"},{"key":"669_CR32","doi-asserted-by":"publisher","first-page":"e505","DOI":"10.1097\/RHU.0000000000001202","volume":"27","author":"K Parperis","year":"2021","unstructured":"Parperis\u00a0K, Constantinidou\u00a0A, Panos\u00a0G (2021) Paraneoplastic arthritides: insights to pathogenesis, diagnostic approach, and treatment. J\u00a0Clin Rheumatol 27:e505\u2013e509. https:\/\/doi.org\/10.1097\/RHU.0000000000001202","journal-title":"J Clin Rheumatol"},{"key":"669_CR33","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1177\/1203475416665601","volume":"21","author":"JK Qiang","year":"2017","unstructured":"Qiang\u00a0JK, Kim\u00a0WB, Baibergenova\u00a0A, Alhusayen\u00a0R (2017) Risk of malignancy in dermatomyositis and polymyositis. J\u00a0Cutan Med Surg 21:131\u2013136. https:\/\/doi.org\/10.1177\/1203475416665601","journal-title":"J Cutan Med Surg"}],"container-title":["Der Schmerz"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00482-022-00669-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00482-022-00669-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00482-022-00669-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T19:08:10Z","timestamp":1668798490000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00482-022-00669-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,19]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["669"],"URL":"https:\/\/doi.org\/10.1007\/s00482-022-00669-3","relation":{},"ISSN":["0932-433X","1432-2129"],"issn-type":[{"value":"0932-433X","type":"print"},{"value":"1432-2129","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,19]]},"assertion":[{"value":"8 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"<b>K.\u00a0Sch\u00fctte<\/b>: A.\u00a0Finanzielle Interessen: K.\u00a0Sch\u00fctte gibt an, dass kein finanzieller Interessenkonflikt besteht. \u2013\u00a0B.\u00a0Nichtfinanzielle Interessen: \u00c4rztliche Leitung Spezialisierte ambulante Palliativversorgung (SAPV), Ober\u00e4rztin, Universit\u00e4ts-PalliativCentrum, Uniklinik Carl Gustav Carus an der Technischen Universit\u00e4t Dresden | Mitgliedschaften: Deutsche Gesellschaft f\u00fcr Palliativmedizin. <b>K.\u00a0Trautmann-Grill<\/b>: A.\u00a0Finanzielle Interessen: K.\u00a0Trautmann-Grill gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Angestellte H\u00e4matoonkologin, Universit\u00e4tsklinikum Dresden | Mitgliedschaften: DGHO, GTH.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf ExternalRef removed.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}